Drug Profile
Research programme: botulinum toxin vaccine - Emergent BioSolutions
Alternative Names: Bivalent botulinum vaccine; rBOTLatest Information Update: 12 Sep 2014
Price :
$50
*
At a glance
- Originator Emergent BioSolutions; Health Protection Agency Porton Down
- Developer Emergent BioSolutions
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Botulism
Most Recent Events
- 12 Sep 2014 No development reported - Preclinical for Botulism in USA and United Kingdom (Parenteral)